Klotho Neurosciences Stock (NASDAQ:KLTO)
Previous Close
$0.41
52W Range
$0.11 - $3.91
50D Avg
$0.34
200D Avg
$0.63
Market Cap
$20.08M
Avg Vol (3M)
$3.23M
Beta
2.23
Div Yield
-
KLTO Company Profile
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.